Age of the company
5 yearsCapital in CHF
25'000Active brands
0Reports for Blueprint Medicines (Switzerland) GmbH
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out moreEconomic information
Comprehensive information about the economic situation of a company. Find out morePayment collection information
Overview of current and past debt enforcement proceedings. Find out moreCompany dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data. Retrieve company dossierAbout Blueprint Medicines (Switzerland) GmbH
- Blueprint Medicines (Switzerland) GmbH with its legal headquarters in Zug is a Limited liability company from the sector «Research and development». Blueprint Medicines (Switzerland) GmbH is active.
- The management of the company Blueprint Medicines (Switzerland) GmbH consists of 4 persons.
- The company has last modified its commercial register entry on 10.12.2021. All previous commercial register entries are available under «Notifications».
- The company is registered in the commercial register of the Canton of ZG under the UID CHE-499.149.707.
- On the same address there are 271 other active companies registered. These include: 7Heal Investments AG in Liquidation, ABAM AG, Acqupart Holding AG.
Commercial register information
Entry in the commercial register
14.08.2018
Legal form
Limited liability company
Legal headquarters of the company
Zug
Commercial Registry Office
ZG
Commercial register number
CH-170.4.015.830-4
UID/VAT
CHE-499.149.707
Sector
Research and development
Purpose (Original language) Customise the company purpose with just a few clicks.
Forschung, Entwicklung, Herstellung, Kommerzialisierung, Nutzung, Erwerb und Vertrieb von pharmazeutischen und diagnostischen Produkten und Technologien; vollständige Zweckumschreibung gemäss Statuten.
Auditor
Current auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Ernst & Young AG | Zug | 05.10.2021 | ||
Former auditor (1)
| Name | City | Since | Until | |
|---|---|---|---|---|
| Ernst & Young AG | Basel | 17.08.2018 | 01.12.2019 | |
Other company names
Past and translated company names
- Blueprint Medicines (Switzerland LLC)
Ownership structure
Holdings
Newest SOGC notifications: Blueprint Medicines (Switzerland) GmbH
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1005354342, Commercial Registry Office Zug, (170)
Blueprint Medicines (Switzerland) GmbH, in Zug, CHE-499.149.707, Gesellschaft mit beschränkter Haftung (SHAB Nr. 193 vom 05.10.2021, Publ. 1005305018).
Eingetragene Personen neu oder mutierend:
Meyer, Georg, deutscher Staatsangehöriger, in München (DE), Vorsitzender der Geschäftsführung, mit Einzelunterschrift.
Publication number: HR02-1005305018, Commercial Registry Office Zug, (170)
Blueprint Medicines (Switzerland) GmbH, in Zug, CHE-499.149.707, Gesellschaft mit beschränkter Haftung (SHAB Nr. 141 vom 23.07.2021, Publ. 1005256513). [gestrichen: Mit Erklärung vom 25.11.2019 wurde auf die eingeschränkte Revision verzichtet.].
Eingetragene Personen neu oder mutierend:
Ernst & Young AG (CHE-152.377.547), in Zug, Revisionsstelle.
Publication number: HR02-1005256513, Commercial Registry Office Zug, (170)
Blueprint Medicines (Switzerland) GmbH, in Zug, CHE-499.149.707, Gesellschaft mit beschränkter Haftung (SHAB Nr. 101 vom 28.05.2021, Publ. 1005195612).
Ausgeschiedene Personen und erloschene Unterschriften:
Beresford, Paul, britischer Staatsangehöriger, in Unterägeri, Direktor, mit Einzelunterschrift.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.